arrow
J

Jadwiga Handzlik

jagiellonian university medical college
H指数:31
被引数:3,140

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Polyfunctionalized N-Arylsulfonyl Indoles: Identification of (E)-N-Hydroxy-3-{3-[(5-(3-(piperidin-1-yl)propoxy]-1H-indol-1-yl)sulfonyl]phenyl}acrylamide (MTP150) for the Epigenetic-based Therapy of Parkinson’s Disease

多官能化N-芳基磺酰基吲哚:用于表观遗传学基础治疗帕金森病的(E)-N-羟基-3-{3-[(5-(3-(哌啶-1-基)丙氧基)-1H-吲哚-1-基)磺酰基]苯基}丙烯酰胺(MTP150)的鉴定

2026-03-310
OAAI
The first-in-class 1,3,5-triazine-derived dual 5-HT6R/FAAH modulators in search for potential drug against neurodegenerative diseases with cognitive impairment

第一类1,3,5-三嗪衍生的双5-HT6R/FAAH调节剂,用于寻找针对伴有认知障碍的神经退行性疾病的潜在药物

2025-08-050
OA
The psychoplastogens ibogaminalog and ibogainalog induce antidepressant-like activity in naive and depressed mice by mechanisms involving 5-HT2A receptor activation and serotonergic transmission

精神激素ibogaminalog和ibogainalog通过涉及5-HT2A受体激活和血清素能传递的机制在幼稚和抑郁小鼠中诱导抗抑郁样活性

2025-01-010
PRE
Contilisant plus Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases
2024-09-100
PRE
First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer's Disease
2024-01-089
OAAI
Hydrophobicity modulation via the substituents at positions 2 and 4 of 1,3,5-triazine to enhance therapeutic ability against Alzheimer's disease for potent serotonin 5-HT6R agents
2023-11-011
OAAI
Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT6R ligands with noticeable action on AChE/BChE and chalcogen-dependent intrinsic activity in search for new class of drugs against Alzheimer's disease
2023-11-018
OAAI
Discovery of novel arylpiperazine-based DA/5-HT modulators as potential antipsychotic agents-Design, synthesis, structural studies and pharmacological profiling
2023-04-014
PRE
Benzophenone Derivatives with Histamine H3 Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of Alzheimer's Disease
2022-12-285
OAAI